[{"address1": "21 Ha\u2019arba\u2019a Street", "city": "Tel Aviv", "zip": "6473921", "country": "Israel", "phone": "972 3 541 3131", "fax": "972 3 541 3144", "website": "https://www.redhillbio.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, advanced unresectable cholangiocarcinoma, prostate cancer, and nuclear radiation protection; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 for pulmonary nontuberculous mycobacteria infections caused by mycobacterium avium complex. The company was incorporated in 2009 and is headquartered in Tel Aviv, Israel.", "fullTimeEmployees": 53, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dror  Ben-Asher", "age": 58, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 594612, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Razi  Ingber", "age": 40, "title": "Chief Financial Officer", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 339819, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gilead  Raday MPhil, MSc", "age": 49, "title": "Chief Operating Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 365556, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adi  Frish", "age": 54, "title": "Chief Corporate & Business Development Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 339300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rick D. Scruggs", "age": 64, "title": "Chief Commercial Officer, President of RedHill Biopharma Inc. & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 469802, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alexandra  Okmian", "title": "Senior Business Development & Investor Relations Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Reza  Fathi Ph.D.", "age": 69, "title": "Senior Vice President of Research & Development", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 299291, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Guy  Goldberg J.D.", "age": 48, "title": "Chief Business Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 338126, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Patricia  Anderson B.Sc. RAC", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.24, "open": 2.2012, "dayLow": 1.8605, "dayHigh": 2.2012, "regularMarketPreviousClose": 2.24, "regularMarketOpen": 2.2012, "regularMarketDayLow": 1.87, "regularMarketDayHigh": 2.2012, "payoutRatio": 0.0, "beta": 4.434, "forwardPE": 65.0, "volume": 41820, "regularMarketVolume": 41820, "averageVolume": 90108, "averageVolume10days": 26900, "averageDailyVolume10Day": 26900, "bid": 1.55, "ask": 2.45, "bidSize": 1, "askSize": 2, "marketCap": 2532387, "fiftyTwoWeekLow": 1.861, "fiftyTwoWeekHigh": 20.275, "priceToSalesTrailing12Months": 0.6831365, "fiftyDayAverage": 4.06058, "twoHundredDayAverage": 7.41536, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 22926178304, "profitMargins": 0.0, "floatShares": 11112341049, "sharesOutstanding": 1298660, "sharesShort": 46646, "sharesShortPriorMonth": 5842, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0359, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.0677, "shortRatio": 0.26, "shortPercentOfFloat": 0.041100003, "impliedSharesOutstanding": 11070800, "bookValue": 0.052, "priceToBook": 37.5, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -30174000, "trailingEps": -302.63, "forwardEps": 0.03, "lastSplitFactor": "1:25", "lastSplitDate": 1724112000, "enterpriseToRevenue": 6184.564, "enterpriseToEbitda": -1094.799, "52WeekChange": -0.851145, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 1.95, "recommendationKey": "none", "totalCash": 7277000, "totalCashPerShare": 0.001, "ebitda": -20941000, "totalDebt": 558000, "quickRatio": 0.389, "currentRatio": 0.74, "totalRevenue": 3707000, "debtToEquity": 914.754, "revenuePerShare": 4.733, "returnOnAssets": -0.44882, "returnOnEquity": -17.086071, "grossProfits": 1262000, "freeCashflow": -5386000, "operatingCashflow": -24230000, "revenueGrowth": -0.284, "grossMargins": 0.34043998, "ebitdaMargins": 0.0, "operatingMargins": -3.2846, "financialCurrency": "USD", "symbol": "RDHL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Redhill Biopharma Ltd.", "longName": "RedHill Biopharma Ltd.", "corporateActions": [], "marketState": "CLOSED", "postMarketTime": 1743805135, "regularMarketTime": 1743796800, "exchange": "NCM", "messageBoardId": "finmb_104926324", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -12.946426, "regularMarketPrice": 1.95, "firstTradeDateMilliseconds": 1357569000000, "postMarketChangePercent": 2.54871, "postMarketPrice": 1.9997, "postMarketChange": 0.0496999, "regularMarketChange": -0.28999996, "regularMarketDayRange": "1.87 - 2.2012", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 90108, "fiftyTwoWeekLowChange": 0.089000106, "fiftyTwoWeekLowChangePercent": 0.04782381, "fiftyTwoWeekRange": "1.861 - 20.275", "fiftyTwoWeekHighChange": -18.324999, "fiftyTwoWeekHighChangePercent": -0.9038224, "fiftyTwoWeekChangePercent": -85.1145, "earningsTimestampStart": 1724934600, "earningsTimestampEnd": 1725193800, "isEarningsDateEstimate": true, "hasPrePostMarketData": true, "epsTrailingTwelveMonths": -302.63, "epsForward": 0.03, "fiftyDayAverageChange": -2.1105797, "fiftyDayAverageChangePercent": -0.519773, "twoHundredDayAverageChange": -5.4653597, "twoHundredDayAverageChangePercent": -0.7370323, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "RedHill Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]